Global Q Fever Market Research Report 2023

Report ID: 1988043 | Published Date: Jan 2025 | No. of Page: 85 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Q Fever Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Acute Q Fever
        1.2.3 Chronic Q Fever
    1.3 Market by Application
        1.3.1 Global Q Fever Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals & Clinics
        1.3.3 Diagnostic Centers
        1.3.4 Surgical Centers
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Q Fever Market Perspective (2017-2028)
    2.2 Q Fever Growth Trends by Region
        2.2.1 Q Fever Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Q Fever Historic Market Size by Region (2017-2022)
        2.2.3 Q Fever Forecasted Market Size by Region (2023-2028)
    2.3 Q Fever Market Dynamics
        2.3.1 Q Fever Industry Trends
        2.3.2 Q Fever Market Drivers
        2.3.3 Q Fever Market Challenges
        2.3.4 Q Fever Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Q Fever Players by Revenue
        3.1.1 Global Top Q Fever Players by Revenue (2017-2022)
        3.1.2 Global Q Fever Revenue Market Share by Players (2017-2022)
    3.2 Global Q Fever Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Q Fever Revenue
    3.4 Global Q Fever Market Concentration Ratio
        3.4.1 Global Q Fever Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Q Fever Revenue in 2021
    3.5 Q Fever Key Players Head office and Area Served
    3.6 Key Players Q Fever Product Solution and Service
    3.7 Date of Enter into Q Fever Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Q Fever Breakdown Data by Type
    4.1 Global Q Fever Historic Market Size by Type (2017-2022)
    4.2 Global Q Fever Forecasted Market Size by Type (2023-2028)
5 Q Fever Breakdown Data by Application
    5.1 Global Q Fever Historic Market Size by Application (2017-2022)
    5.2 Global Q Fever Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Q Fever Market Size (2017-2028)
    6.2 North America Q Fever Market Size by Country (2017-2022)
    6.3 North America Q Fever Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Q Fever Market Size (2017-2028)
    7.2 Europe Q Fever Market Size by Country (2017-2022)
    7.3 Europe Q Fever Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Q Fever Market Size (2017-2028)
    8.2 Asia-Pacific Q Fever Market Size by Country (2017-2022)
    8.3 Asia-Pacific Q Fever Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Q Fever Market Size (2017-2028)
    9.2 Latin America Q Fever Market Size by Country (2017-2022)
    9.3 Latin America Q Fever Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Q Fever Market Size (2017-2028)
    10.2 Middle East & Africa Q Fever Market Size by Country (2017-2022)
    10.3 Middle East & Africa Q Fever Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Yashica Pharmaceuticals Private Limited (India)
        11.1.1 Yashica Pharmaceuticals Private Limited (India) Company Detail
        11.1.2 Yashica Pharmaceuticals Private Limited (India) Business Overview
        11.1.3 Yashica Pharmaceuticals Private Limited (India) Q Fever Introduction
        11.1.4 Yashica Pharmaceuticals Private Limited (India) Revenue in Q Fever Business (2017-2022)
        11.1.5 Yashica Pharmaceuticals Private Limited (India) Recent Development
    11.2 Merck & Co. (US)
        11.2.1 Merck & Co. (US) Company Detail
        11.2.2 Merck & Co. (US) Business Overview
        11.2.3 Merck & Co. (US) Q Fever Introduction
        11.2.4 Merck & Co. (US) Revenue in Q Fever Business (2017-2022)
        11.2.5 Merck & Co. (US) Recent Development
    11.3 Atox Bio (Israel)
        11.3.1 Atox Bio (Israel) Company Detail
        11.3.2 Atox Bio (Israel) Business Overview
        11.3.3 Atox Bio (Israel) Q Fever Introduction
        11.3.4 Atox Bio (Israel) Revenue in Q Fever Business (2017-2022)
        11.3.5 Atox Bio (Israel) Recent Development
    11.4 Teva Pharmaceutical Industries (Israel)
        11.4.1 Teva Pharmaceutical Industries (Israel) Company Detail
        11.4.2 Teva Pharmaceutical Industries (Israel) Business Overview
        11.4.3 Teva Pharmaceutical Industries (Israel) Q Fever Introduction
        11.4.4 Teva Pharmaceutical Industries (Israel) Revenue in Q Fever Business (2017-2022)
        11.4.5 Teva Pharmaceutical Industries (Israel) Recent Development
    11.5 Basilea Pharmaceutica Ltd. (Switzerland)
        11.5.1 Basilea Pharmaceutica Ltd. (Switzerland) Company Detail
        11.5.2 Basilea Pharmaceutica Ltd. (Switzerland) Business Overview
        11.5.3 Basilea Pharmaceutica Ltd. (Switzerland) Q Fever Introduction
        11.5.4 Basilea Pharmaceutica Ltd. (Switzerland) Revenue in Q Fever Business (2017-2022)
        11.5.5 Basilea Pharmaceutica Ltd. (Switzerland) Recent Development
    11.6 MELINTA THERAPEUTICS(US)
        11.6.1 MELINTA THERAPEUTICS(US) Company Detail
        11.6.2 MELINTA THERAPEUTICS(US) Business Overview
        11.6.3 MELINTA THERAPEUTICS(US) Q Fever Introduction
        11.6.4 MELINTA THERAPEUTICS(US) Revenue in Q Fever Business (2017-2022)
        11.6.5 MELINTA THERAPEUTICS(US) Recent Development
    11.7 Pfizer (US)
        11.7.1 Pfizer (US) Company Detail
        11.7.2 Pfizer (US) Business Overview
        11.7.3 Pfizer (US) Q Fever Introduction
        11.7.4 Pfizer (US) Revenue in Q Fever Business (2017-2022)
        11.7.5 Pfizer (US) Recent Development
    11.8 Cipla Inc. (India)
        11.8.1 Cipla Inc. (India) Company Detail
        11.8.2 Cipla Inc. (India) Business Overview
        11.8.3 Cipla Inc. (India) Q Fever Introduction
        11.8.4 Cipla Inc. (India) Revenue in Q Fever Business (2017-2022)
        11.8.5 Cipla Inc. (India) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Q Fever Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Acute Q Fever
    Table 3. Key Players of Chronic Q Fever
    Table 4. Global Q Fever Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Q Fever Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Q Fever Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Q Fever Market Share by Region (2017-2022)
    Table 8. Global Q Fever Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Q Fever Market Share by Region (2023-2028)
    Table 10. Q Fever Market Trends
    Table 11. Q Fever Market Drivers
    Table 12. Q Fever Market Challenges
    Table 13. Q Fever Market Restraints
    Table 14. Global Q Fever Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Q Fever Market Share by Players (2017-2022)
    Table 16. Global Top Q Fever Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Q Fever as of 2021)
    Table 17. Ranking of Global Top Q Fever Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Q Fever Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Q Fever Product Solution and Service
    Table 21. Date of Enter into Q Fever Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Q Fever Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Q Fever Revenue Market Share by Type (2017-2022)
    Table 25. Global Q Fever Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Q Fever Revenue Market Share by Type (2023-2028)
    Table 27. Global Q Fever Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Q Fever Revenue Market Share by Application (2017-2022)
    Table 29. Global Q Fever Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Q Fever Revenue Market Share by Application (2023-2028)
    Table 31. North America Q Fever Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Q Fever Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Q Fever Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Q Fever Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Q Fever Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Q Fever Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Q Fever Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Q Fever Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Q Fever Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Q Fever Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Yashica Pharmaceuticals Private Limited (India) Company Detail
    Table 42. Yashica Pharmaceuticals Private Limited (India) Business Overview
    Table 43. Yashica Pharmaceuticals Private Limited (India) Q Fever Product
    Table 44. Yashica Pharmaceuticals Private Limited (India) Revenue in Q Fever Business (2017-2022) & (US$ Million)
    Table 45. Yashica Pharmaceuticals Private Limited (India) Recent Development
    Table 46. Merck & Co. (US) Company Detail
    Table 47. Merck & Co. (US) Business Overview
    Table 48. Merck & Co. (US) Q Fever Product
    Table 49. Merck & Co. (US) Revenue in Q Fever Business (2017-2022) & (US$ Million)
    Table 50. Merck & Co. (US) Recent Development
    Table 51. Atox Bio (Israel) Company Detail
    Table 52. Atox Bio (Israel) Business Overview
    Table 53. Atox Bio (Israel) Q Fever Product
    Table 54. Atox Bio (Israel) Revenue in Q Fever Business (2017-2022) & (US$ Million)
    Table 55. Atox Bio (Israel) Recent Development
    Table 56. Teva Pharmaceutical Industries (Israel) Company Detail
    Table 57. Teva Pharmaceutical Industries (Israel) Business Overview
    Table 58. Teva Pharmaceutical Industries (Israel) Q Fever Product
    Table 59. Teva Pharmaceutical Industries (Israel) Revenue in Q Fever Business (2017-2022) & (US$ Million)
    Table 60. Teva Pharmaceutical Industries (Israel) Recent Development
    Table 61. Basilea Pharmaceutica Ltd. (Switzerland) Company Detail
    Table 62. Basilea Pharmaceutica Ltd. (Switzerland) Business Overview
    Table 63. Basilea Pharmaceutica Ltd. (Switzerland) Q Fever Product
    Table 64. Basilea Pharmaceutica Ltd. (Switzerland) Revenue in Q Fever Business (2017-2022) & (US$ Million)
    Table 65. Basilea Pharmaceutica Ltd. (Switzerland) Recent Development
    Table 66. MELINTA THERAPEUTICS(US) Company Detail
    Table 67. MELINTA THERAPEUTICS(US) Business Overview
    Table 68. MELINTA THERAPEUTICS(US) Q Fever Product
    Table 69. MELINTA THERAPEUTICS(US) Revenue in Q Fever Business (2017-2022) & (US$ Million)
    Table 70. MELINTA THERAPEUTICS(US) Recent Development
    Table 71. Pfizer (US) Company Detail
    Table 72. Pfizer (US) Business Overview
    Table 73. Pfizer (US) Q Fever Product
    Table 74. Pfizer (US) Revenue in Q Fever Business (2017-2022) & (US$ Million)
    Table 75. Pfizer (US) Recent Development
    Table 76. Cipla Inc. (India) Company Detail
    Table 77. Cipla Inc. (India) Business Overview
    Table 78. Cipla Inc. (India) Q Fever Product
    Table 79. Cipla Inc. (India) Revenue in Q Fever Business (2017-2022) & (US$ Million)
    Table 80. Cipla Inc. (India) Recent Development
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Q Fever Market Share by Type: 2021 VS 2028
    Figure 2. Acute Q Fever Features
    Figure 3. Chronic Q Fever Features
    Figure 4. Global Q Fever Market Share by Application in 2021 & 2028
    Figure 5. Hospitals & Clinics Case Studies
    Figure 6. Diagnostic Centers Case Studies
    Figure 7. Surgical Centers Case Studies
    Figure 8. Q Fever Report Years Considered
    Figure 9. Global Q Fever Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Q Fever Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Q Fever Market Share by Region: 2021 VS 2028
    Figure 12. Global Q Fever Market Share by Players in 2021
    Figure 13. Global Top Q Fever Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Q Fever as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Q Fever Revenue in 2021
    Figure 15. North America Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Q Fever Market Share by Country (2017-2028)
    Figure 17. United States Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Q Fever Market Share by Country (2017-2028)
    Figure 21. Germany Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Q Fever Market Share by Region (2017-2028)
    Figure 29. China Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Q Fever Market Share by Country (2017-2028)
    Figure 37. Mexico Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Q Fever Market Share by Country (2017-2028)
    Figure 41. Turkey Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Q Fever Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Yashica Pharmaceuticals Private Limited (India) Revenue Growth Rate in Q Fever Business (2017-2022)
    Figure 44. Merck & Co. (US) Revenue Growth Rate in Q Fever Business (2017-2022)
    Figure 45. Atox Bio (Israel) Revenue Growth Rate in Q Fever Business (2017-2022)
    Figure 46. Teva Pharmaceutical Industries (Israel) Revenue Growth Rate in Q Fever Business (2017-2022)
    Figure 47. Basilea Pharmaceutica Ltd. (Switzerland) Revenue Growth Rate in Q Fever Business (2017-2022)
    Figure 48. MELINTA THERAPEUTICS(US) Revenue Growth Rate in Q Fever Business (2017-2022)
    Figure 49. Pfizer (US) Revenue Growth Rate in Q Fever Business (2017-2022)
    Figure 50. Cipla Inc. (India) Revenue Growth Rate in Q Fever Business (2017-2022)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Yashica Pharmaceuticals Private Limited (India)
Merck & Co. (US)
Atox Bio (Israel)
Teva Pharmaceutical Industries (Israel)
Basilea Pharmaceutica Ltd. (Switzerland)
MELINTA THERAPEUTICS(US)
Pfizer (US)
Cipla Inc. (India)
Frequently Asked Questions
Q Fever report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Q Fever report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Q Fever report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Quantum Dot Display

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More